Latest filing published 07 Aug 2012 for BIOCANCELL THERAPEUTICS INC., €732k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Clal Biotechnology Industries Ltd.: trading record in brief
This profile gathers the share dealings of Clal Biotechnology Industries Ltd. in Biocancell Therapeutics Inc. Between 24 January 2012 and 31 July 2012, the trades on record add up to 4 filings.
The open-market record is one-sided, with 2 purchases worth €3.5M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 7 August 2012 came the latest disclosure, a transaction for €732k in Biocancell Therapeutics Inc. The latest purchase dates back some time: it was published 5,207 days ago, on 7 August 2012. Typically, a trade is published a median of 25 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Clal Biotechnology Industries Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,147,171 shares@ US$0.217Common stockSEC:0001178913-12-002171:0
- 10,731,726 shares@ US$0.217Common stockSEC:0001178913-12-002171:1Canonical exit: 29 Oct 2012 (T+90)
- 8,199,400 shares@ US$0.26Common stockSEC:0001178913-12-000620:0Canonical exit: 23 Apr 2012 (T+90)
- 410,392 shares0Common stockSEC:0001178913-12-000620:1
4 of 4 declarations